KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Share-based Compensation (2016 - 2025)

Tenet Healthcare's Share-based Compensation history spans 17 years, with the latest figure at $25.0 million for Q4 2025.

  • For Q4 2025, Share-based Compensation rose 66.67% year-over-year to $25.0 million; the TTM value through Dec 2025 reached $104.0 million, up 55.22%, while the annual FY2025 figure was $104.0 million, 55.22% up from the prior year.
  • Share-based Compensation for Q4 2025 was $25.0 million at Tenet Healthcare, down from $38.0 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $38.0 million in Q3 2025 and bottomed at $9.0 million in Q4 2022.
  • The 5-year median for Share-based Compensation is $16.0 million (2021), against an average of $17.4 million.
  • The largest annual shift saw Share-based Compensation tumbled 30.77% in 2022 before it surged 137.5% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $13.0 million in 2021, then crashed by 30.77% to $9.0 million in 2022, then skyrocketed by 100.0% to $18.0 million in 2023, then decreased by 16.67% to $15.0 million in 2024, then surged by 66.67% to $25.0 million in 2025.
  • Per Business Quant, the three most recent readings for THC's Share-based Compensation are $25.0 million (Q4 2025), $38.0 million (Q3 2025), and $20.0 million (Q2 2025).